Optic Neuritis Treatment Market

Market Overview
The global Optic Neuritis Treatment Market is projected to experience a high CAGR during the forecast period from 2023 to 2030.

Understanding Optic Neuritis
Optic neuritis is a condition characterized by inflammation or irritation of the nerve to the eye. It may occur due to a specific disease or without any known cause. Individuals with optic neuritis may later develop multiple sclerosis. Common symptoms include pain with eye movement and temporary vision loss in one eye. While optic neuritis may resolve spontaneously, poor visual function may be treated with steroids, such as IV methylprednisolone, to speed up recovery. If steroid therapy fails, plasma exchange therapy is considered.

Market Dynamics
Increasing Demand for Novel Therapeutics
The market is witnessing a growing demand for innovative therapeutics, aiming to address unmet needs in optic neuritis treatment. Horizon Therapeutics, for example, shared positive data from a late-stage study of Uplizna in patients with neuromyelitis optica spectrum disorder (NMOSD), characterized by optic neuritis. FDA approvals for novel therapeutics, such as Genentech's Enspryng, contribute to increased patient trust and better treatment outcomes.

Advancements in Treatment and Increasing Clinical Trials
The market benefits from ongoing advancements, including regulatory approvals, clinical trials, and increased awareness. Positive data from studies and FDA approvals, such as for Genentech's Enspryng, demonstrate progress in optic neuritis treatment. The rising prevalence of optic neuritis and continuous efforts in the development of novel drugs and therapies contribute to market growth.

Request For Free Sample: https://www.datamintelligence.com/download-sample/optic-neuritis-treatment-market

Market Restraints
Factors such as complications and side effects associated with high doses of corticosteroids, the high cost of treatment, and the absence of more effective treatment options are expected to impede market growth.

Optic Neuritis Treatment Market Segment Analysis
The global optic neuritis treatment market is segmented based on disease type, treatment type, distribution channel, and region.

Intravenous Corticosteroids Segment: Accounting for approximately 45.3% of the market share, this segment is expected to hold the largest market share over the forecast period. Intravenous corticosteroids, administered through infusion for three days, are used to reduce inflammation around the optic nerves, shortening the duration of optic neuritis symptoms. Their wide availability, acceptability, and ease of application contribute to their dominance.

Geographical Shares
North America Dominates the Market
North America, especially the United States, is expected to hold the largest market share. The region boasts a strong presence of major players, advanced healthcare facilities, and active research and clinical activities related to optic neuritis treatment. The well-established healthcare infrastructure and increasing research activities contribute to the development of advanced therapeutics.

Market Companies
Major global players in the optic neuritis treatment market include Pfizer Inc., MERCK & CO., Inc., EyePoint Pharmaceuticals, Inc., Novartis AG, Genentech, Inc., Mallinckrodt plc, Alcon Inc., NIKSAN PHARMACEUTICAL, AbbVie Inc., and Hubei Gedian Humanwell Pharmaceutical Co., Ltd., among others.

COVID-19 Impact Analysis
The global optic neuritis treatment market faced significant disruptions during the COVID-19 pandemic. Non-urgent treatments were postponed, and clinical trials and research activities were temporarily disrupted. The redirection of focus to the pandemic and related restrictions affected the industry, including disruptions in the global supply chain for optic neuritis treatment drugs.

Related Reports:

https://www.datamintelligence.com/download-sample/lupus-nephritis-treatment-market

https://www.datamintelligence.com/download-sample/optical-disorders-drugs-market

https://www.datamintelligence.com/download-sample/optical-brightener-market

Media Contact
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com/

About DataM Intelligence
DataM Intelligence 4Market Research is a Market Research firm that provides end-to-end business solutions to organizations from Research to Consulting. We at DataM Intelligence leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of Syndicate Reports & and; Customized Reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries, catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.